We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Simulating Surgery Helps Reduce Implant Complications

By HospiMedica staff writers
Posted on 07 May 2008
A computer surgery-simulation breakthrough could mean fewer medical complications and better surgical outcomes for patients undergoing hip, knee, or spinal implant surgery.

The OrthoSim platform is a system using computer software to create anatomical and implant simulations. More...
Set up to develop an orthopedic surgery planning tool, the platform can significantly reduce the risk of post-operative complications, as well as provide a means for testing new implant devices. The simulation models are based on the work of two leading European biomechanics research centers; the lumbar spinal region model is the result of over 20 years of research at the biomechanical lab of the L'Ecole Nationale Superieure d'Arts et Metiers (ENSAM, Paris, France), while the lumbar implant model was provided by the Instituto de Biomecánica de Valencia (Spain). The models were combined to provide a reliable simulation of the interface between the artificial implant and the living tissue. The platform can be used to study the suitability of new implant devices and can help pinpoint any problems with the design at an early stage. The models are linked together and are hosted at an online service.

"Initially we had a model just for lumbar spine implants, but in the last months we have almost completed a validated model for hip implants,” said Dr. Ing. Ruben Lafuente, coordinator of the OrthoSim project at Adapting (Paterna, Spain), the company directing the project. "We believe that once we finish perfecting a model for knee implants we will have a very strong set of tools to offer surgeons.”

"About 10% of operations have complications, often requiring a new implant, or a further surgery,” added Dr. Lafuente. "It means increased pain and inconvenience, a drain on human resources and of course it is expensive, too.”

A follow-on project, called OrthoTraining, is taking the OrthoSim toolset a step further; over the next two years, OrthoTraining's researchers plan to develop a surgical training tool based on OrthoSim's work.


Related Links:
L'Ecole Nationale Superieure d'Arts et Metiers
Instituto de Biomecánica de Valencia
Adapting

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.